Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:09 PM
Ignite Modification Date: 2025-12-24 @ 11:09 PM
NCT ID: NCT06028269
Eligibility Criteria: Control group: Inclusion Criteria (Control): * Able to speak, read and understand Danish/English Exclusion Criteria (Control): * Pain from the neck or shoulder area during the past 6 months * Experience of delayed onset muscle soreness (DOMS) during the week leading up to the test session * Former surgery in neck or shoulder * Current or previous chronic or recurrent pain condition that could affect the results * Pregnancy * Drug addiction defined as the use of cannabis, opioids or other drugs * Previous neurologic, musculoskeletal or mental illnesses that could affect the results * Regular use of analgesics * Abnormally disrupted sleep in the last 24 hours preceding the experiment * Lack of ability to cooperate Neck pain group: Inclusion Criteria (Neck Pain): * Idiopathic neck pain * Able to speak, read and understand Danish/English * Reduced/painful active range of motion of the head and/or painful reaction to palpation of the neck at the time of inclusion Exclusion Criteria (Neck Pain): * Experience of DOMS during the week leading up to the test session * Former surgery in neck or shoulder * Pregnancy * Drug addiction defined as the use of cannabis, opioids or other drugs * Previous neurologic, musculoskeletal (other than neck pain) or mental illnesses that could affect the results * Abnormally disrupted sleep in the 24 hours preceding the experiment * Lack of ability to cooperate
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 50 Years
Study: NCT06028269
Study Brief:
Protocol Section: NCT06028269